लोड हो रहा है...
Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide
Multiple myeloma is a hematologic malignancy that predominantly affects older adults, with a median age at diagnosis of 70 years old. A mainstay of multiple myeloma treatment is lenalidomide, which is an immunomodulatory drug (IMiD) that changed the treatment paradigm for multiple myeloma. This is p...
में बचाया:
| में प्रकाशित: | Clin Interv Aging |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Dove
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7210019/ https://ncbi.nlm.nih.gov/pubmed/32440105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S196087 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|